1. Home
  2. GMM vs ATNM Comparison

GMM vs ATNM Comparison

Compare GMM & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

N/A

Current Price

$1.29

Market Cap

39.6M

Sector

N/A

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.65

Market Cap

47.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GMM
ATNM
Founded
2017
2000
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.6M
47.1M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GMM
ATNM
Price
$1.29
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
17.1K
163.1K
Earning Date
08-18-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.79
N/A
Revenue
$48,171,048.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$42,943.57
P/E Ratio
$0.71
N/A
Revenue Growth
41.74
11.11
52 Week Low
$1.13
$1.03
52 Week High
$4.97
$2.41

Technical Indicators

Market Signals
Indicator
GMM
ATNM
Relative Strength Index (RSI) 39.40 65.53
Support Level $1.13 $1.48
Resistance Level $1.41 $1.69
Average True Range (ATR) 0.10 0.09
MACD 0.01 0.03
Stochastic Oscillator 44.43 88.89

Price Performance

Historical Comparison
GMM
ATNM

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: